SIGA · Siga Technologies Inc
$3.44
-0.12 (-3.37%)
At close · Jul 17
Market Cap
$246.73M
Shares
71.72M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Diem Nguyen | CEO | $3,244,492 |
| Daniel J. Luckshire | CFO | $1,567,217 |
| Dennis E. Hruby | Executive Vice President and Chief Scientific Officer | $1,559,428 |
| Larry Miller | General Counsel | $1,538,982 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Diem Nguyen | CEO | $4,449,790 |
| Larry Miller | General Counsel | $2,188,014 |
| Daniel J. Luckshire | CFO | $1,460,684 |
| Dennis E. Hruby | Executive Vice President and Chief Scientific Officer | $1,453,450 |
| Jay K. Varma | Former Executive Vice President and Chief Medical Officer | $548,295 |
| Phillip L. Gomez | CEO | $138,527 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Phillip L. Gomez | CEO | $1,825,856 |
| Dennis E. Hruby | Executive Vice President and Chief Scientific Officer | $1,811,114 |
| Daniel J. Luckshire | CFO | $1,718,140 |
| Jay K. Varma | Former Executive Vice President and Chief Medical Officer | $670,534 |
| Diem Nguyen | CEO | — |
| Larry Miller | General Counsel | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Phillip L. Gomez | CEO | $1,738,912 |
| Dennis E. Hruby | Executive Vice President and Chief Scientific Officer | $1,411,116 |
| Daniel J. Luckshire | CFO | $1,384,375 |
| Robin E. Abrams | General Counsel | $186,121 |
| Diem Nguyen | CEO | — |
| Larry Miller | General Counsel | — |
| Jay K. Varma | Former Executive Vice President and Chief Medical Officer | — |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Phillip L. Gomez | CEO | $1,688,264 |
| Daniel J. Luckshire | CFO | $1,311,272 |
| Dennis E. Hruby | Executive Vice President and Chief Scientific Officer | $1,304,776 |
| Robin E. Abrams | General Counsel | $1,239,088 |
| Jay K. Varma | Former Executive Vice President and Chief Medical Officer | — |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Phillip L. Gomez | CEO | $1,639,090 |
| Dennis E. Hruby | Executive Vice President and Chief Scientific Officer | $1,466,772 |
| Daniel J. Luckshire | CFO | $1,273,080 |
| Robin E. Abrams | General Counsel | $1,102,998 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Daniel J. Luckshire | CFO | $1,684,000 |
| Phillip L. Gomez | CEO | $1,591,350 |
| Robin E. Abrams | General Counsel | $1,518,872 |
| Dennis E. Hruby | Executive Vice President and Chief Scientific Officer | $1,429,876 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Phillip L. Gomez | CEO | $1,545,000 |
| Daniel J. Luckshire | CFO | $1,200,000 |
| Dennis E. Hruby | Executive Vice President and Chief Scientific Officer | $1,194,054 |
| Robin E. Abrams | General Counsel | $1,159,382 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Phillip L. Gomez | CEO | $1,662,329 |
| Dennis E. Hruby | Executive Vice President and Chief Scientific Officer | $1,247,276 |
| Daniel J. Luckshire | CFO | $1,043,348 |
| Robin E. Abrams | General Counsel | $1,009,400 |
Key facts
CIK
1010086
CUSIP
826917106
13F (30d)
10 filings
10 filers
Visit website
Investor relations